News - Latest

Request to take over the pyridoxine hydrochloride marketing authorisation

The company Pharmachemie B.V. has requested the Medicines Evaluation Board (MEB) to withdraw marketing authorisation for ...

News item | 30-03-2020 | 17:00

Changes to product information policy

The Medicines Evaluation Board (MEB) recently revised a number of policy documents for pharmaceutical companies relating to the ...

News item | 23-03-2020 | 12:00

Coronavirus - MEB employees work from home

Complying with the Dutch government guidelines regarding the coronavirus situation, MEB employees will be working from home as of ...

News item | 13-03-2020 | 15:30

Regulatory Science Magazine 10: Reduction, replacement and refinement of animal studies

This week, the newest edition of the Regulatory Science Magazine was issued. This 10th edition of the online science magazine of ...

News item | 10-03-2020 | 15:00

Amended policy on DHPCs

The Medicines Evaluation Board (MEB) has amended its policy on Direct Healthcare Professional Communications (DHPCs). This ...

News item | 21-02-2020 | 12:00

MEB confirms current legal status of supply ibuprofen 200 mg

The Medicines Evaluation Board (MEB) has evaluated whether the recent European review of the adverse events on heart and blood ...

News item | 03-08-2015 | 00:00

Decision regarding the Brinzolamide objection

The Medicines Evaluation Board (MEB) has made a decision regarding an objection by Alcon Laboratories (UK) Ltd.

News item | 17-07-2015 | 10:30

New Veterinary Medicinal Products Regulation and Medicated Feed Regulation have come into force

News item | 28-01-0022 | 10:40